According to Immuneering's latest financial reports the company's current EPS (TTM) is -HK$14.97. In 2022 the company made an earnings per share (EPS) of -HK$14.89 a decrease over its 2021 EPS that were of -HK$13.07.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$15.13 | 1.56% |
2022 | -HK$14.89 | 13.92% |
2021 | -HK$13.07 | 33.64% |
2020 | -HK$9.78 |